<DOC>
	<DOCNO>NCT01748578</DOCNO>
	<brief_summary>This First-In-Human ( FIH ) study assess safety tolerability ocular administration EBI-005 healthy volunteer . Additionally , PK immunogenicity EBI-005 assess .</brief_summary>
	<brief_title>Phase 1 Study Safety Tolerability EBI-005 Topically Administered Eyes Healthy Adult Subjects</brief_title>
	<detailed_description>The plan dose level 5 mg/mL EBI-005 ( Group 1 ) 20 mg/mL EBI-005 ( Group 2 ) . A total 8 subject dose group subject randomize ratio 6:2 , EBI-005 : placebo . Treatment administration Group 2 proceed follow review safety data Group 1 . In group , subject randomize active treatment receive EBI-005 right eye placebo leave eye . Subjects randomize placebo receive placebo eye .</detailed_description>
	<criteria>Healthy adult male and/or female age 18 65 year Medically healthy Best correction vision great equal 20/40 eye Nontobacco/nicotinecontaining product user minimum 6 month prior dose Tolerate topical administration eye Signed dated , Institutional Review Board ( IRB ) approve informed consent form ( ICF ) prior protocolspecific screening procedure History presence significant cardiovascular , pulmonary , hepatic , renal , hematological , gastrointestinal , endocrine , immunologic , dermatologic ( include sensitive skin face ) , neurological , psychiatric disease , clinically significant disease deem acceptable PI History primary malignancy , exception basal cell squamous cell carcinoma skin cervical carcinoma situ malignancy curatively treat evidence disease least 5 year Occurrence active seasonal allergy include ocular allergy ( e.g . ; annual hay fever ) Abnormalities follow ophthalmological examination : abnormality cornea , evidence ocular inflammation ( dry eye , blepharitis , allergic conjunctivitis , iritis , uveitis ) , glaucoma , optic neuropathy Subjects history laser refractive surgery ( laser assist stromal insitu keratomileusis [ LASIK ] , photorefractive keratectomy [ PRK ] ) , radial keratotomy ( RK ) , corneal transplantation , dry eye , radiotherapy eye Use contact lenses currently within past one year Positive urine drug/alcohol cotinine test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Healthy</keyword>
	<keyword>Interleukin 1 Receptor Inhibitor</keyword>
	<keyword>Dry Eye</keyword>
</DOC>